WallStreetZenWallStreetZen

NYSE: VAPO
Vapotherm Inc Stock Forecast, Predictions & Price Target

Analyst price target for VAPO

Based on 1 analyst offering 12 month price targets for Vapotherm Inc.
Min Forecast
$1.00-66.89%
Avg Forecast
$1.00-66.89%
Max Forecast
$1.00-66.89%

Should I buy or sell VAPO stock?

Based on 1 analyst offering ratings for Vapotherm Inc.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%

Be the first to know when Wall Street analysts revise their VAPO stock forecasts and price targets.

VAPO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is VAPO forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is VAPO forecast to generate an efficient return on assets?
Company
N/A
Industry
10.69%

VAPO revenue forecast

What is VAPO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$70.0M+3.49%
Avg 2 year Forecast
$79.7M+17.84%
Avg 3 year Forecast
$87.9M+30.09%
VAPO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VAPO revenue growth forecast

How is VAPO forecast to perform vs Medical Devices companies and vs the US market?
Company
8.23%
Industry
5.7%
Market
6.55%
VAPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VAPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VAPO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VAPO$3.25$1.00-69.23%Strong Sell
NRXS$3.00N/AN/A
SSKN$0.44N/AN/A
BMRA$0.89N/AN/A
NSYS$9.20N/AN/A

Vapotherm Stock Forecast FAQ

Is Vapotherm Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: VAPO) stock is to Strong Sell VAPO stock.

Out of 1 analyst, 0 (0%) are recommending VAPO as a Strong Buy, 0 (0%) are recommending VAPO as a Buy, 0 (0%) are recommending VAPO as a Hold, 0 (0%) are recommending VAPO as a Sell, and 1 (100%) are recommending VAPO as a Strong Sell.

If you're new to stock investing, here's how to buy Vapotherm stock.

What is VAPO's revenue growth forecast for 2023-2025?

(NYSE: VAPO) Vapotherm's forecast annual revenue growth rate of 8.23% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.55%.

Vapotherm's revenue in 2023 is $67,598,000.On average, 2 Wall Street analysts forecast VAPO's revenue for 2023 to be $429,437,777, with the lowest VAPO revenue forecast at $426,614,144, and the highest VAPO revenue forecast at $432,261,410. On average, 2 Wall Street analysts forecast VAPO's revenue for 2024 to be $488,948,915, with the lowest VAPO revenue forecast at $486,217,357, and the highest VAPO revenue forecast at $491,680,473.

In 2025, VAPO is forecast to generate $539,805,004 in revenue, with the lowest revenue forecast at $536,367,538 and the highest revenue forecast at $543,242,471.

What is VAPO's forecast return on assets (ROA) for 2023-2025?

(NYSE: VAPO) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.69%.

What is VAPO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VAPO price target, the average VAPO price target is $1.00, with the highest VAPO stock price forecast at $1.00 and the lowest VAPO stock price forecast at $1.00.

The Wall Street analyst predicted that Vapotherm's share price could fall to $1.00 by Nov 9, 2024. The average Vapotherm stock price prediction forecasts a potential downside of 69.23% from the current VAPO share price of $3.25.

What is VAPO's forecast return on equity (ROE) for 2023-2025?

(NYSE: VAPO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.